These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27502007)

  • 21. Retinoids inhibit differentiation of hematopoietic osteoclast progenitors.
    Conaway HH; Persson E; Halén M; Granholm S; Svensson O; Pettersson U; Lie A; Lerner UH
    FASEB J; 2009 Oct; 23(10):3526-38. PubMed ID: 19546303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-IFN-γ Antibody Promotes Osteoclastogenesis in Human Bone Marrow Monocyte-Derived Macrophages Co-Cultured with Tuberculosis-Activated Th1 Cells.
    Deng J; Sun D; Luo F; Zhang Q; Chen F; Xu J; Zhang Z
    Cell Physiol Biochem; 2018; 49(4):1512-1522. PubMed ID: 30205409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
    Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
    RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NADPH oxidase gp91
    Kang IS; Kim C
    Sci Rep; 2016 Nov; 6():38014. PubMed ID: 27897222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
    Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
    J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cysteinyl leukotriene receptor 1 (cysLT1R) regulates osteoclast differentiation and bone resorption.
    Zheng C; Shi X
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S64-S70. PubMed ID: 30183378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory clusterin inhibits osteoclastogenesis by attenuating M-CSF-dependent osteoclast precursor cell proliferation.
    Choi B; Kang SS; Kang SW; Min BH; Lee EJ; Song DH; Kim SM; Song Y; Yoon SY; Chang EJ
    Biochem Biophys Res Commun; 2014 Jul; 450(1):105-9. PubMed ID: 24866235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
    Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N
    Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL.
    Tsujisawa T; Inoue H; Nishihara T
    J Bone Miner Res; 2005 Jan; 20(1):15-22. PubMed ID: 15619665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG oligonucleotides: novel regulators of osteoclast differentiation.
    Zou W; Schwartz H; Endres S; Hartmann G; Bar-Shavit Z
    FASEB J; 2002 Mar; 16(3):274-82. PubMed ID: 11874977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells.
    Nagasawa T; Arai M; Togari A
    Arch Oral Biol; 2011 Sep; 56(9):924-31. PubMed ID: 21377143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice.
    Hayashi S; Tsuneto M; Yamada T; Nose M; Yoshino M; Shultz LD; Yamazaki H
    Endocrinology; 2004 Jun; 145(6):2721-9. PubMed ID: 14988381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
    Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RANKL pretreatment plays an important role in the differentiation of pit-forming osteoclasts induced by TNF-α on murine bone marrow macrophages.
    Yamashita Y; Ukai T; Nakamura H; Yoshinaga Y; Kobayashi H; Takamori Y; Noguchi S; Yoshimura A; Hara Y
    Arch Oral Biol; 2015 Sep; 60(9):1273-82. PubMed ID: 26099662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans.
    Yu H; Herbert BA; Valerio M; Yarborough L; Hsu LC; Argraves KM
    Lipids Health Dis; 2015 Jul; 14():66. PubMed ID: 26138336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pulsed electromagnetic fields on the expression of NFATc1 and CAII in mouse osteoclast-like cells.
    He J; Zhang Y; Chen J; Zheng S; Huang H; Dong X
    Aging Clin Exp Res; 2015 Feb; 27(1):13-9. PubMed ID: 24869857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.